18
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Long-term Pathologic Changes of α1-Acid Glycoprotein (orosomucoid) Glycoforms in Autoimmune Thyroid Disease

, , , &
Pages 441-447 | Published online: 07 Jul 2009

  • Bories, PN., Feger, J., Benbemou, N., Rouzeau, J.D., Agneray, J. and Durand, G. (1990) "Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity". Inflammation 14, 315-323.
  • Schmid, K. (1975) In: Putman, F.W., ed. Plasma Protein, 2nd Ed. (Academic Press, New York), pp. 185-227.
  • Bog-Hansen, T.C. (1973) "Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography". Anal. Biochem 56, 480-488.
  • Bog-Hansen, T.C., Bjerrum, O.J. and Ramlau, J. (197) "Detection of biospecific interaction during in first dimension electrophoresis". Scand, J. Immunol. 4, 141-417.
  • Bayard, B., Kerckaert, J.P. Laine, A. and Hayem, A. (1982) "Uniformity of glycans within molecular variants of alpha-protease inhibitor with distinct affinity forconcanavalin A", Eur. J. Biochem. 124, 371-376.
  • van Dijk, W., Havenaar, B.C. and Brinkman-van der Linden, B.C. (1995) "Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function". Glycoconj. J. 12, 227-233.
  • Treuheit, M.J., Costello, C.E. and Halsall, H.B. (1992) "Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein". Biochem. J. 283 (Pt 1), 105-112.
  • Hansen, J.E., Bog-Hansen, T.C., Pedersen, B. and Neland, K. (1989) "Microheterogeneity of orosomucoid in pathological conditions". Electrophoresis 10, 574-578.
  • Hansen, J.E., Iversen, J., Lihme, A. and Bog-Hansen, T.C. (1987) "Acute phase reaction, heterogeneity, and microheterogeneity of serum proteins as nonspecific tumor markers in lung cancer". Cancer 60, 1630-1635.
  • Hansen, J.E., Larsen, V.A. and Bog-Hansen, T.C. (1984) "The microheterogeneity of alpha 1-acid glycoprotein in inflammatory lung disease, cancer of the lung and normal health". Clin. Chim. Acta 138, 41-47.
  • Shiyan, S.D. and Bovin, N.V. (1997) "Carbohydrate composition and immunomodulatory activity of different glycoforms of alphal acid glycoprotein". Glycoconj. J. 14, 631-638.
  • Halken, P., Bog-Hansen, T.C. and Prause, J.U. (1986) "Differences between glycoprotein profiles of normal tear fluid and of tear fluid from patients with primary Sjogren's syndrome". Scand. J. Rheumatol. Suppl. 61, 234-236.
  • Mackiewiez, A. and Mackiewiez. K. (1995) "Glycoforms of serum alpha 1 -acid glycoprotein as markers of inflammation and cancer". Glycoconj. J. 12, 241-247.
  • Hrycaj, P., Sobieska, M., Mackiewiez, S. and Muller, W. (1993) "Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis". J. Rheumatol. 20, 2020-2024.
  • Rasmussen, A.K., Feldt-Rasmussen, U. and Bendtzen, K. (1993) "The effect of interleukin-1 on the thyroid gland". Autoimmunin 16. 141-148.
  • Bech, K. (1983) "Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins". Acta Endocrinol. Suppl. (Copenh.) 254, 3-38.
  • Rapoport, B., McLachlan, S.M., Kakinuma, A. and Chazenbalk, G.D. (1996) "Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate". J. Clin. Endocrinol. Metab. 81, 2525-2533.
  • Feldt-Rasmussen, U. (1996) "Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor". Clin. Chem. 42, 160-163.
  • Zimmermann-Belsing, T. Rasmussen, A.K., Feldt-Rasmussen, U. and Bog-Hansen. T.C. (2001) "The influence of alphal-acid glycoportein (orosomucoid) and its glycoforms on the function of human thyrocytes and CHO cells transfected with the human TSH receptor". Mol. Cell Endocrinol., 188, 241-251.
  • Schott, M., Feldkamp, J., Bathan, C., Fritzen, R., Scherbaum, W.A. and Seissler, J. (2000) "Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation", Horm. Metab. Res. 32, 429-435.
  • Massart, C., Orgiazzi, J. and Maugendre, D. (2001) "Clinical validity of a new commercial method for detection of TSH- receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs". Clin. Chim. Acta 304, 39-47.
  • Feldt-Rasmussen, U., Hoier-Madsen, M., Bech, K., Blichert-Toft, M., Bliddal, H., Date, J., Danneskiold-Samsoe, B., Hegedus, L., Hippe, E. and Homnes, P.J. (1991) "Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases". Autoimmunity 9, 245-254.
  • Bog-Hansen, T.C. (1997) In: Rhodes, J.M. and Milton, J.D., eds, Lectins Methods and Protocols. Methods in Molecular Medicine Volume 9 (Humana Press, Totowa, NJ. USA), pp. 227-333.
  • Hagerup, M., Conradsen, K., Bog-Hansen, T.C., Bouchelouche, P. and Schafer Nielsen. C. (1988) "Cream: PC-based computer vision". Proceeding of the Sixth Meeting of the International Electrophoresis Society, pp. 369-373.
  • Bog-Hansen, T.C. (1980) In: Radola, B.J., eds, Electrophoresis 79. Advanced Methods. Biochemical and Clinical Applications (Walter de Gruyter. Berlin) vol. 1, p 194.
  • Breborowiez, J. and Mackiewiez, A. (1989) "Affinity electrophoresis for diagnosis of cancer and inflammatory conditions". Electrophoresis 10, 568-573.
  • Raynes, J. (1982) "Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease". Biomed. Pharmacother 36, 77-86.
  • Heegaard, P.M., Bienvenu, J., Sabbagh, I., Delvil, A., Laurent, P. and Bog-Hansen, T.C. (1984) In: Arnaud, P. Bienvenu, J. and Laurent, P., eds, Marker Proteins in Inflammation (Walter de Gruyter. Berlin/New York), pp. 540-548.
  • Mackiewiez, A. and Kushner, I. (1989) "Affinity electrophoresis for studies of mechanisms regulating glycosylation of plasma proteins". Electrophoresis 10, 830-835.
  • Pos, O., Oostendorp, R.A., van der Stelt, M.E., Schepe r. R.J. and van Dijk, W. (1990) "Con A-nonreactive human alpha 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants". Inflammation 14, 133-141.
  • Bennett, M. and Schmid, K. (1980) "Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety". Pm: Proc. Acad. Sci. USA 77, 6109-6113.
  • Schmid, K., Kaufmann, H., Isemura, S., Bauer, F., Emura, J., Motoyama, T. and Ishiguro, M. (1973) "Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins". Biochemistry 12, 2711 -2724.
  • Ikenaka, T., Ishiguro, M., Emura, J., Kaufmann, H., Isemura, S., Bauer, W. and Schmid, K. (1972) "Isolation and partial characterization of the cyanogen bromide fragments of 1 -acid glycoprotein and the elucidation of the amino acid sequence of the carboxyl-terminal cyanogen bromide fragment". Biochemistry 11, 3817-3829.
  • Pos, O., van Dijk, W., Ladiges, N., Linthorst, C. Sala, M., van Tiel, D. and Boers, W. (1988) "Glycosylation of four acute-phase glycoproteins secreted by rat liver cells in vivo and in vitro. Effects of inflammation and dexamethasone". Eur. J. Cell Biol. 46, 121-128.
  • Feldt-Rasmussen, U. (1983) "Serum thyroglobulin and thyroglobulin autoantibodies in thyroid diseases. Pathogenic and diagnostic aspects". Allergy 38, 369-387.
  • Murakami, M., Miyashita, K., Mizuma, H., Yamada, M., Iriuchijima, T., Takeuchi, T. and Mori, M. (1996) "Discrete characteristics of antibodies raised against thyrotropin receptorrelated peptides whose sequences are not conserved in the luteinizing hormone/chorionic gonadotropin receptor". J. Clin. Endocrinol. Metab. 81, 1747-1752.
  • Tahara, K., Ishikawa, N., Yamamoto, K., Hirai, A., Ito, K., Tamura, Y., et al. (1997) "Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor". Thyroid 7, 867-877.
  • Rasmussen, A.K. (2000) "Cytokine actions on the thyroid gland". Dan. Med. Bull. 47, 94-114.
  • Feldt-Rasmussen, U., Schleusener, H. and Carayon. P (1994) "Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease". J. Clin. Endocrinol. Metab. 78, 98-102.
  • Davies, T.F., Roti, E., Braverman, L.E. and DeGroot, L. (1998) "Thyroid controversy-Stimulating antibodies". J. Clin. Endocrinol. Metab 83, 3777-3785.
  • Costagliola, S., Morgenthaler, N.G., Hoermann, R., Badenhoop, K., Struck, J., Freitag, D., Poertl, S., Weglohner, W., Hollidt, J.M., Quadbeck, B., Dumont, J.E., Schumm-Draeger, P. Bergmann, A., Mann, K., Vassart, G. and Usadel, K.H. (1999) "Second generation assay for thyrotropin receptor antibodies has superior diagnostic sesitivity for Graves' disease". J. Clin. Endocrinol. Metab. 84, 90-97.
  • Giovanella, L., Ceriani, L. and Garancini, S. (2001) "Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test". Clin. Chem. Lab. Med. 39, 25-28.
  • Maugendre, D. and Massart, C. (2001) "Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay". Clin. Endocrinol. (Oxf.) 54, 89-96.
  • Muller, M.J. and Seitz, H.J. (1984) "Thyroid hormone action on intermediary metabolism. Part III. Protein metabolism in hyper- and hypothyroidism". Klin. Wochenschr: 62, 97-102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.